Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9068aa2001d07c3bea38a89d11626cea |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-526 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2851 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-283 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-32 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
filingDate |
2019-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a99522a3b1f3896c9a3f64fd55ad7cab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebaa335c4592c013ec5700d13486b7e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_329373276e8b41784e5992b855b8c2a4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ee01afc403b71c393fbb490cadfe1094 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c8067dfa1b0384daa0493f682c0ea77 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16e6d5b868116bf5596053e3703d21ae http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5beaf063fe379bc77de4e5231d5d62db |
publicationDate |
2020-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
BR-112020016939-A2 |
titleOfInvention |
MULTI-SPECIFIC BINDING PROTEINS THAT BIND TO CD33, NKG2D, AND CD16 AND METHODS OF USE |
abstract |
These are multispecific binding proteins that bind to and exterminate human cancer cells that express CD33 (Siglec-3), as well as pharmaceutical compositions and therapeutic methods useful for the treatment of cancer that expresses CD33. The invention relates to multispecific binding proteins that bind to human cancer cells that express CD33 and exhibit high potency and maximum lysis of target cells compared to anti-CD33 monoclonal antibodies. |
priorityDate |
2018-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |